• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Enforcement Report - Week of December 18, 2024

    FDA

    Enforcement Report - Week of November 13, 2024

    FDA

    Somerset`s Generics Timolol Receives Approval in US

    FDA

    Glenmark receives ANDA approval for Brimonidine Tartrate & Timolol Maleate

    INDINPHARMAPOST

    Glenmark`s Generic Brimonidine Tartrate;Timolol Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of May 15, 2024

    FDA

    Enforcement Report - Week of June 7, 2023

    FDA

    Sentiss` Generic Timolol Maleate Receives Receives Approval in the U.S.

    FDA

    Thea Pharma Statement Related to Akorn`s Recall of Various Human & Animal Drug

    PR NEWSWIRE

    Enforcement Report - Week of January 25, 2023

    FDA

    Enforcement Report - Week of January 4, 2023

    FDA

    Upsher`s Generic Brimonidine Tartrate and Timolol Maleate Receives Approval in the U.S.

    FDA

    Akorn`s Generic Brimonidine Tartrate, Timolol Maleate Receives Approval in the U.S.

    FDA

    Watson`s Generic Brimonidine Tartrate, Timolol Maleate Receives Approval in the U.S.

    FDA

    Gland`s Generic Dorzolamide HCL,Timolol Maleate Receives Approval in the U.S.

    FDA

    Ingenus` Generic Timolol Maleate Receives Approval in the U.S.

    FDA

    Micro`s Generic Timolol Maleate Receives Approval in the U.S.

    FDA

    Amring Pharma Announces Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%

    BUSINESSWIRE

    Apotex`s Generic Brimonidine Tartrate;Timolol Receives Approval in the U.S.

    FDA

    Sandoz`s Generic Brimonidine Tartrate and Timolol Maleate Receives Approval in the U.S.

    FDA

    Micro Lab`s Generic Dorzolamide Hydrochloride and Timolol Acetate Receives Approval in the U.S.

    FDA

    Glaukos Completes Patient Enrollment in US NDA Ph3 Clinical Trials for iDose TR

    BUSINESSWIRE

    Alembic Pharma bags USFDA nod for Dorzolamide HCL and Timolol Maleate Ophthalmic

    GOOGLE

    Alembic Pharms Generic Timolol Maleate Receives Approval in US

    FDA

    New Products launched by Micro Labs USA Inc

    PRNEWSWIRE

    Akorn Inc`s Generic Timolol Maleate Receives Approval In US

    FDA

    Enforcement Report - Week of July 1, 2020

    FDA

    Santen EMEA announces RWD on Taptiqom

    PHARMATIMES

    Enforcement Report - Week of August 7, 2019

    FDA

    Somerset Therapeutics` Generic Dorzolamide Hydrochloride, Timolol Maleate Receives Approval In US

    FDA

    Invatech Pharma`s Generic Timolol Maleate Receives Approval in US

    FDA

    Enforcement Report - Week of April 3, 2019

    FDA

    Imprimis Pharmaceuticals Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of September 13, 2017

    FDA

    Forbidden Xalacom Eye Drops of Pfizer

    ANVISA

    Mundipharma buys Merck`s ophthalmology business

    BIOSPECTRUM ASIA

    UPDATED: Aerie skyrockets on a mixed success in second PhIII glaucoma study

    FIERCE BIOTECH

    Apotex` Generic Timolol Maleate (EQ 0.5% BASE) Approved in USA For Ocular Hypertension

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.